Defense World
29 Mar 2026, 08:42 UTC · 30w ago
Impact · against what's priced in
The analyst consensus for OrthoPediatrics is positive, but the news is a lagging indicator of existing sentiment rather than a fundamental catalyst. The 'Moderate Buy' rating provides a baseline of support but lacks new material data to shift the stock's valuation.
No priced-in read yet
What the story claims
2 claims · scored −1 bearish … +1 bullish
Eight out of eleven brokerages covering OrthoPediatrics Corp. have issued a 'buy' recommendation.
So whatStrong analyst consensus typically supports positive price action and investor confidence in a stock.
More positive than 77% of claims this week
The average recommendation for OrthoPediatrics Corp. is currently a 'Moderate Buy'.
Continue reading
5 related stories
Eight out of eleven brokerages issuing buy recommendations suggests a strong bullish consensus, providing positive momentum for the stock.
Read from the article alone
Scored by the NIS engine · methodology.
More positive than 50% of claims this week
Which stocks this story touches
More positive than 77% of ticker scores this week
The company has a 'Moderate Buy' consensus with the majority of analysts issuing buy recommendations.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
13h ago
+53.5%
Price agrees with the score
$23.82 vs $15.52 close before publication (Mar 27) · not market-adjusted
KIDS chart →
